About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Moving humanity forward.
The Weizmann Institute has a culture of creative collaboration and intellectual curiosity, free from commercial restraints.
Prof. Zelig Eshhar pioneered cancer immunotherapy by developing CAR-T cells, which harness the patient’s immune system to fight disease. A treatment based on his method has resulted in total remission in many leukemia patients. CAR-T gene therapy made history as the first such treatment approved by the FDA.
Fighting CancerWorking with partners like Microsoft, our scientists are blending technology and biology to help computers “see,” with applications in medical imaging, robotics, healthcare, tracking seismic activity, and security.
Advancing TechnologyIn the 1970s, Weizmann launched Perach, a mentoring program that pairs university students with children from underprivileged backgrounds. Today, Perach is a national success story, with around 15% of all college students in Israel and tens of thousands of children taking part each year.
Enriching EducationAn Institute hydrologist invented a method of removing chemicals from groundwater, transforming hazardous pollutants into harmless oxygen and carbon. This patented technology could revolutionize pollution treatment.
Protecting Our PlanetMultiple sclerosis (MS) affects 2.5 million people worldwide. Our research led to Copaxone® and Rebif®, two FDA-approved drugs that are now frontline treatments for MS.
Improving Health & MedicineOur scientists were on the history-making team that identified the Higgs boson–the “God particle”–at Geneva’s Large Hadron Collider (LHC), the strongest particle accelerator ever built. Institute physicists are leading ongoing LHC projects that examine some of the universe’s greatest mysteries.
Exploring the Physical World